In the version of the article originally published, the ExoInTouch product being used by Pfizer in its virtual trial for overactive bladder (OAB) is eDiary, not Recruit, which allows patients to report through mobile phone or internet portals. The Recruit technology is being used in other studies. The text references to Recruit have been replaced with an explanation of eDiary. Instead of "new technology to recruit patients faster and in a more standardized fashion, " the text now reads, "new technology to allow home-based clinical trial data reporting. " Instead of "'Recruit' text messaging technology in a pilot study" for Detrol, the text now reads, "'eDiary' tool in a Phase 4 trial, called Research on Electronic Monitoring of OAB Treatment Experience. " Additional explanation has been added, including "Patients can respond to simple questionnaires (Fig. 3) via their mobile phones or home computers. If they delay in responding, a reminder can be sent. " And for space reasons, other text relating to Recruit, "The tool is integrated with Pfizer's volunteer database and allows immediate text message-based communication and assessment of a subject's suitability within 5-10 min" and "It can also be used to send protocol-specific messages to patients already enrolled in trials" was deleted. In addition, it should have been noted that Eric Westin, who was interviewed while senior director of Lilly Oncology, had left the company. The errors have been corrected in the HTML and PDF versions of the article. In the version of this article initially published, BASF's Amflora, a genetically modified potato for industrial use, was mistakenly said to be blight resistant when it is not. The error has been corrected in the HTML and PDF versions of the article. In the version of this article initially published, the accession code to obtain raw sequence data was given as SRA045736.2; the correct code is SRA045736. The error has been corrected in the HTML and PDF versions of the article. In the version of this article initially published online, in the Online Methods "Ion Torrent Sequencing" section, the sentence beginning with "Ten milligrams of this DNA was fragmented with a Bioruptor instrument…. " should have read "Ten micrograms…. " and in the "454 GS Junior sequencing" section, "(500 total)" should have read "(500 ng total). " The errors have been corrected in the PDF and HTML versions of this article.
